Alkermes stock jumps on positive ADHD drug trial results

disease outbreak active 85% Health

Alkermes stock jumped following positive results from ADHD drug trials, signaling potential market success and improved treatment options for patients. The development highlights pharmaceutical sector advancements.

🌐 Location: CY — Sources: 6 — First seen: — Last seen:
Alkermes stock jump ADHD drug trials pharmaceuticals

Linked Entities

Alkermes

organization responder

Quest Diagnostics

organization responder

Labcorp

organization responder

AnaptysBio

organization responder

Craneware

organization responder

BMO Capital

organization responder

Contributing Articles